Paper7199538
Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
Sakata Y and 1 other. J Clin Invest, 1982. Cited by 268 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. Papers, record 7199538. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7199538
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrin | Major topic |
| Fibrinolysis | Major topic |
| Hemostasis | Major topic |
| alpha-2-Antiplasmin | Major topic |
| Calcium | |
| Factor XIII | |
| Humans | |
| Plasminogen | |
| Plasminogen Activators |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,974,323 | [A quantitative determination of factor 13 with anti-factor 13 serum]. | Thromb Diath Haemorrh | 1968 | https://conductscience.org/library/papers/4974323 | PubMed |
| 2 | 5,806,584 | The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. | J Biol Chem | 1969 | https://conductscience.org/library/papers/5806584 | PubMed |
| 3 | 5,105,032 | A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme wtih phenylmethylsulfonyl fluoride. | Biochemistry | 1971 | https://conductscience.org/library/papers/5105032 | PubMed |
| 4 | 4,257,942 | Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. | Biochim Biophys Acta | 1972 | https://conductscience.org/library/papers/4257942 | PubMed |
| 5 | 4,623,561 | Kinetic studies with transglutaminases. The human blood enzymes (activated coagulation factor 13 and the guinea pig hair follicle enzyme. | J Biol Chem | 1972 | https://conductscience.org/library/papers/4623561 | PubMed |
| 6 | 5,065,068 | Solid state lactoperoxidase: a highly stable enzyme for simple, gentle iodination of proteins. | Biochem Biophys Res Commun | 1972 | https://conductscience.org/library/papers/5065068 | PubMed |
| 7 | 4,405,643 | Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. | J Biol Chem | 1973 | https://conductscience.org/library/papers/4405643 | PubMed |
| 8 | 1,158,872 | Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. | J Biol Chem | 1975 | https://conductscience.org/library/papers/1158872 | PubMed |
| 9 | 134,998 | Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. | J Biol Chem | 1976 | https://conductscience.org/library/papers/134998 | PubMed |
| 10 | 136,345 | Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. | Eur J Biochem | 1976 | https://conductscience.org/library/papers/136345 | PubMed |
| 11 | 137,718 | The primary inhibitor of plasmin in human plasma. | Biochem J | 1976 | https://conductscience.org/library/papers/137718 | PubMed |
| 12 | 1,011,990 | Fibrin-stabilizing factor (factor XIII). | Methods Enzymol | 1976 | https://conductscience.org/library/papers/1011990 | PubMed |
| 13 | 68,962 | The behavior of alpha2-plasmin inhibitor in fibrinolytic states. | J Clin Invest | 1977 | https://conductscience.org/library/papers/68962 | PubMed |
| 14 | 144,728 | Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor. | J Biochem | 1977 | https://conductscience.org/library/papers/144728 | PubMed |
| 15 | 147,116 | Fast-acting plasmin inhibitor in human plasma. | Blood | 1978 | https://conductscience.org/library/papers/147116 | PubMed |
| 16 | 76,519 | The alpha2-plasmin inhibitor levels in liver diseases. | Clin Chim Acta | 1978 | https://conductscience.org/library/papers/76519 | PubMed |
| 17 | 77,050 | Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin. | Thromb Haemost | 1978 | https://conductscience.org/library/papers/77050 | PubMed |
| 18 | 659,588 | Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. | J Clin Invest | 1978 | https://conductscience.org/library/papers/659588 | PubMed |
| 19 | 151,345 | Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate. | Thromb Res | 1978 | https://conductscience.org/library/papers/151345 | PubMed |
| 20 | 154,122 | Natural inhibitors of fibrinolysis. | Prog Cardiovasc Dis | 1979 | https://conductscience.org/library/papers/154122 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 268 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,982,814 | Transglutaminase 2 contributes to the blood clotting cascade. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42982814 | PubMed |
| 41,303,589 | Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side Effects. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303589 | PubMed |
| 39,519,297 | Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519297 | PubMed |
| 38,706,781 | Connecting impaired fibrinolysis and dyslipidemia. | Res Pract Thromb Haemost | 2024 | https://conductscience.org/library/papers/38706781 | PubMed |
| 37,332,750 | All tangled up: interactions of the fibrinolytic and innate immune systems. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37332750 | PubMed |
| 37,153,474 | "Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37153474 | PubMed |
| 36,531,720 | "Going with the flow" in modeling fibrinolysis. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36531720 | PubMed |
| 36,452,200 | Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target. | TH Open | 2022 | https://conductscience.org/library/papers/36452200 | PubMed |
| 35,328,366 | The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35328366 | PubMed |
| 35,163,216 | Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163216 | PubMed |
| 34,967,721 | Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism. | Blood Transfus | 2022 | https://conductscience.org/library/papers/34967721 | PubMed |
| 34,830,419 | Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830419 | PubMed |
| 33,540,604 | Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33540604 | PubMed |
| 33,426,005 | Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease. | Front Cardiovasc Med | 2020 | https://conductscience.org/library/papers/33426005 | PubMed |
| 31,258,531 | Fibrinolysis and Inflammation in Venous Thrombus Resolution. | Front Immunol | 2019 | https://conductscience.org/library/papers/31258531 | PubMed |
| 29,779,246 | Regulation of plasminogen activation on cell surfaces and fibrin. | J Thromb Haemost | 2018 | https://conductscience.org/library/papers/29779246 | PubMed |
| 29,723,259 | Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin. | PLoS One | 2018 | https://conductscience.org/library/papers/29723259 | PubMed |
| 29,378,352 | Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis. | Thromb Haemost | 2018 | https://conductscience.org/library/papers/29378352 | PubMed |
| 29,080,382 | Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking. | J Thromb Haemost | 2018 | https://conductscience.org/library/papers/29080382 | PubMed |
| 28,761,875 | Inhibition of Fibrinolysis by Coagulation Factor XIII. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28761875 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PLG | 5,340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| SERPINF2 | 5,345 | PubTator's text mining | https://conductscience.org/library/genes/5345 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7199538
GET https://conductscience.org/api/papers/v1/7199538/references?page=2